5-Bromo-3-cyclopropyl-4-methylpyridine, 95+%, 500mg

Ruthenium(III) chloride hydrate, 97.0%, 10g

5-(Methoxycarbonyl)-2-nitrobenzoic acid, 95.0%, 1g

Ethyl 2-amino-3-cyano-4,5,6,7-tetrahydrobenzo[b]thiophene-4-carboxylate, 95+%, 1g

tert-Butyl 2,6-dimethyl-4-oxopiperidine-1-carboxylate, 95.0%, 10g

4-CHLORO-2-HYDROXY-N-METHOXY-N-METHYLBENZAMIDE, 95.0%, 500mg

2-(Quinolin-8-yloxy)acetic acid hydrochloride, 95+%, 250mg

5-Nitropyridin-3-amine hydrochloride, 97%, 100mg

Myristic acid, min. 98%, for biochemistry, 100 g, plastic packaging.

TERT-BUTYL 3-(BENZYLAMINO)-3-(2-ETHOXY-2-OXOETHYL)AZETIDINE-1-CARBOXYLATE, 95.0%, 5g

2'-Deoxy-2'-fluorocytidine hydrate, 95.0%, 1g

Flat flange reaction vial, cylindrical, graduated, with tempering jacket KF connecting piece, DN 150, 5000 ml, 190 mm, 1 Piece

1-Naphthaldehyde, 97.0%, 100g